February 13, 2012

Valeant Pharmaceuticals is set to acquire a privately owned ophthalmic biotechnology company, the drug maker said Monday.

February 6, 2012

Mylan has completed its acquisition of two skin drugs from Valeant Pharmaceuticals, the generic drug maker said Monday.

February 2, 2012

Acosta Sales and Marketing on Wednesday announced it has completed the acquisition of Griffin Strategic Advisors and will form a new business unit called AMG Strategic Advisors.

February 1, 2012

Ever wonder how the convenient care industry blossomed into what it is today? One could say a fortune cookie.

January 26, 2012

Drug maker Amgen is acquiring a Rockville, Md.-based company developing therapies for cancer, the companies said Thursday.

January 11, 2012

PZ Cussons, a consumer products group in Europe, Asia and Africa, is expanding its beauty division with the acquisition of the Fudge hair care brand from Australia-based Sabre Group.

January 9, 2012

Bristol-Myers Squibb is buying Inhibitex for $2.5 billion, the companies said.

December 23, 2011

In an effort to focus on its digital growth initiatives and accelerate its transformation to a digital company, Eastman Kodak said it is selling its Eastman Gelatine business to Rousselot, which is part of the Vion Food Group.

December 22, 2011

A Swiss drug maker is acquiring the U.S. rights for several GlaxoSmithKline drugs.

December 16, 2011

Medbox has acquired Prescription Vending Machines and will operate it as a wholly owned subsidiary, Medbox said.

December 8, 2011

According to a report published Wednesday on the site of MobiHealthNews, the Food and Drug Administration has approved an iPhone glucose meter called AgaMatrix Nugget from Sanofi.

December 7, 2011

Helen of Troy has signed a definitive agreement to acquire all assets of Procter & Gamble's water purification brand.

December 7, 2011

The Department of Health and Human Services on Wednesday denied a request made by Teva Pharmaceuticals to relax merchandising restrictions for the emergency contraceptive Plan B.

December 5, 2011

Philosophy, which was acquired by the Coty prestige portfolio in 2010, has announced the newest addition to its Miracle Worker collection — the Miracle Worker Miraculous All-Over brightener and dark spot corrector.

December 5, 2011

Following the settlement of a patent-litigation suit with Swiss drug maker Novartis over the patch Vivelle-Dot (estradiol transdermal system), a drug for treating symptoms of menopause, Mylan said it had received a patent license to begin selling its version of the drug in December 2013.


December 2, 2011

Brynwood Partners VI announced Friday that it acquired Newhall Labs — whose brands include La bella, Monkey Brains and GroWorks — through its wholly owned subsidiary Golden Sun Holdings, which marks Brynwood VI’s third acquisition in the personal care sector.

December 2, 2011

Unilever is looking to close the Alberto-Culver plant outside of Chicago in Melrose Park in 2013, and, in a few months, will begin laying off at least 600 employees, according to a Chicago Sun-Times report.

December 2, 2011

Six retailers on Wednesday filed suit naming Wyeth and Teva Pharmaceuticals as defendants and alleging that the defendants unlawfully delayed the entry of generic versions of Wyeth's antidepressant Effexor XR (venlafaxine).

November 22, 2011

Pfizer will acquire a San Diego-based drug maker focused on treatments for skin scarring, the company said Tuesday.

November 21, 2011

This holiday season, CVS/pharmacy is striving to make it easier than ever for customers to save on Christmas gifts and holiday necessities by enabling CVS/pharmacy's ExtraCare Rewards members to take advantage of special incentives, such as free gift cards for purchasing select items and earning back "free CVS money" called ExtraBucks Rewards on a variety of essentials.

November 21, 2011

Drug maker Gilead Sciences will acquire Pharmasset for $11 billion, or $137 per share, Gilead said Monday.

November 17, 2011

Pharmacy benefit manager SXC Health Solutions is buying PBM service company HealthTrans for $250 million, SXC said Thursday.

November 16, 2011

SoloHealth, a consumer-driven healthcare technology company, on Wednesday said Stanley Blaylock, former Walgreens SVP and former president of Walgreens Health Services, will join SoloHealth’s board of directors.

November 11, 2011

An appeals court has thrown out an attempt by Teva Pharmaceutical Industries to stop Watson Pharmaceuticals from selling a generic contraceptive, Watson said.